Displaying 101–125 of 251 results for Paul Thomas, Senior Editor
FDA's liaison in Europe, Janice Soreth, discusses international harmonization and the API joint inspection pilot project.
A discussion with Bill Ciambrone, Senior Vice President of Technical Operations for Shire Human Genetic Therapies, about critical issues in workforce training today.
As FDA probes the connection between workforce training and quality, manufacturers must do the same.
Consultant Steve Sawin answers our questions about managing contingent labor.
As drug manufacturers struggle to train their workers, solution providers step in to help.
How drug manufacturers can overcome the "44th Hour Problem" and other challenges associated with a variable workforce.
It may be hard to find good help, but its also hard to find good work.
Manufacturers look outside their walls for flow chemistry expertise.
If Ashton Kutcher were in pharma, hed be on LinkedIn.
A look at what microbiologists do and want, by the numbers, and commentary from consultant Pascal Yvon.
Digital signatures have grown in sophistication and import, becoming a staple of serious and compliant drug manufacturers, explains SAFE-Biopharma's Mollie Shields-Uehling.
A look into the laboratory's integrated, and on-demand, future with Thermo Fisher expert Kim Shah.
Manufacturers must practice a heightened sense of "Pharmecovigilance" regarding drug compounds leaving their facilities as waste, says a leading expert.
We have little grasp of the downstream impact of API's being discharged from our facilities.
A recent U.S. Geological Survey study found two drug facilities in New York state releasing high levels of API into local groundwater. The manufacturers have been less than cooperative, says study lead Patrick Phillips, speaking with Senior Editor Paul Thomas. Without adequate studies, Phillips ...
Microsoft is positioning SharePoint as a solution to the industry's innovation gap. In this interview with Senior Editor Paul Thomas at DIA 2010, Michael Naimoli, Director of Life Sciences Industry Solutions, discusses how manufacturers like GSK and Merck are using SharePoint as a knowledge ...
Lean Six Sigma, expertise in microbiology, and shop-floor experience all contribute to running a flexible, efficient contract facility, says DPTs new director of sterile ops.
Is pharma's transformation from a batch-only universe now upon us?
If supplier audits could be harmonized and shared amongst trusted partners, "we could effectively revolutionize the entire industry" and make our supply chains much safer, says Sigma-Aldrich's Tom Beil.
After evaluating technologies, Lonza Biologics is implementing a Raman-based raw materials identification process. QC manager Derek Hubley explains why, and how.
With real-time, wireless and other new monitoring technologies, pharma gains better control of temperature, pressure, humidity, and more.
A gradual transition to better C&Q practices is warranted, as is "getting rid of wasteful, bureaucratic practices that have developed over the years," says Abbott's David Dolgin.
Leveraging PAT and QbD promises significant environmental dividends
Feeding the minds of tomorrow's science-based professionals . . . with cookies.